Notably, similar to kidney diseases, the biosynthesis of SPMs, such as ANXA1, NO, and LXA4, is reduced in CF patients, and the levels of SPMs in the respiratory tract are correlated with lung function in CF patients (172). Here, ANXA1 is linked to cystic fibrosis.